| Unique ID issued by UMIN | UMIN000015126 |
|---|---|
| Receipt number | R000017362 |
| Scientific Title | A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer. |
| Date of disclosure of the study information | 2014/09/12 |
| Last modified on | 2018/10/10 16:42:18 |
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.
A clinical study to evaluate the efficacy of BMA for the patients of PCa.
A clinical study to evaluate the efficacy of bone-modyfying agent for the patients of prostate cancer.
A clinical study to evaluate the efficacy of BMA for the patients of PCa.
| Japan |
prostate cancer
| Urology |
Malignancy
NO
To evaluate the efficasy of BMA for patients of PCa
Efficacy
SRE
QOL
bone fracture
pain
Observational
| 20 | years-old | <= |
| 99 | years-old | >= |
Male
patients of prostate cancer
patients who don't want to participate in this study
| 1st name | |
| Middle name | |
| Last name | Mototsugu Oya |
Keio University School of Medicine
Department of Urology
35 Shinjuku-ku, Tokyo 160-8582, Japan
03-3353-1211
moto-oya@z3.keio.jp
| 1st name | |
| Middle name | |
| Last name | Takeo Kosaka |
Keio University School of Medicine
Department of Urology
35 Shinjuku-ku, Tokyo 160-8582, Japan
03-3353-1211
takemduro@a6.keio.jp
Department of Urology, Keio University School of Medicine
self funding
Self funding
NO
慶應義塾大学病院
| 2014 | Year | 09 | Month | 12 | Day |
Unpublished
Completed
| 2014 | Year | 08 | Month | 22 | Day |
| 2014 | Year | 08 | Month | 22 | Day |
We get information from medical records.
| 2014 | Year | 09 | Month | 11 | Day |
| 2018 | Year | 10 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017362